Navigation Links
Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia®
Date:11/17/2010

formation (www.byetta.com/pi) and Medication Guide (www.byetta.com/mg).

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

Through a long-standing commitment to diabetes care, Lilly seeks to provide patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been an industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients. For more information about Lilly's current diabetes products, visit www.lillydiabetes.com.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

This press release contains forward-loo
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... W.Va. , July 23, 2014 /PRNewswire-iReach/ -- The ... a new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) ... Medical Institute (WVMI). Effective August 1, WVMI ... West Virginia , Pennsylvania ... Jersey and Louisiana.  The Network will engage ...
(Date:7/23/2014)... 23, 2014 Creekridge Capital, an independent ... new vendors so far in 2014 to their ... vendors are from both the healthcare and technology ... large, well-known multi-national companies. Each of these new ... financing products including: standard leasing products, subscription solutions, ...
(Date:7/23/2014)... 2014  When it comes to welcoming our new robot ... roll out the red carpet. Healthcare is one ... 9000-like robots into our human sphere. With healthcare concerns top ... need to apply new technologies to help with old problems. ... robotics is expected to increase from $1.7 billion now to ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Creekridge Capital Signs Several New Vendor Partners 2
... Aug. 26 The Oregon Tourism Commission,launched its ... Program,(Q Care) this week on http://www.OregonQCare.com ., ... created to support the tourism and,hospitality industry through ... customer service, the training will equip,employees with tools ...
... Semafore Pharmaceuticals Inc.,announced data presented at the ... Washington, D.C., showing additional antiangiogenic,activity of vascular-targeted PI3 ... Bv8 signaling., PI3K is part of a ... been shown to play a major role in ...
Cached Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3
(Date:7/23/2014)... VA (PRWEB) July 23, 2014 Inventor ... America: From football games to the gas pump – ... guests on Wednesday, July 30 at Noon. , With ... Legislator has more patents than anyone in the General ... football’s superimposed yellow line yard marker as seen on ...
(Date:7/23/2014)... The National Institute of Biomedical Imaging and Bioengineering ... Symposium on July 30, 2014 on the NIH campus. ... investigators covering a wide breadth of NIBIB-funded research. ... Cohen, Harvard, Engineering Microbial Rhodopsins as Optical Voltage Sensor, ... Fluorescently Labeled Probes for Nerve Imaging ...
(Date:7/23/2014)... Bodybuilding.com, the Internet’s most-visited bodybuilding and fitness ... has officially opened the polls for their tenth annual ... growing sports nutrition company, is up for eight awards ... Best Tasting Protein of the Year- Whey-HD™, Most Innovative ... - Whey-HD™, Pre-workout Supplement of the Year - 1.M.R ...
(Date:7/23/2014)... 23, 2014 Olympic gold medal-winning speed ... Virginia on Friday, July 18. Hedrick visited Roanoke as ... Commonwealth Games, an Olympic-style event celebrating its 25th Anniversary ... as a premier sponsor of the Commonwealth Games, which ... all ages and all activity levels. , Hedrick, a ...
(Date:7/23/2014)... effort to catalog the molecular causes of stomach ... have identified four subtypes of tumors based on ... the new classification promises to advance clinical research ... killer worldwide. , In a report in ... Research Network said they analyzed 295 samples of ...
Breaking Medicine News(10 mins):Health News:Celebrating Innovation and Invention 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... had a piercing somewhere other than their ear lobe, with ... in a hospital admission, according to a study published on ... public health doctors from the Health Protection Agency and the ... women are three times more likely than men to have ...
... Key, WASHINGTON, June 13 A team ... to Germany on Saturday,to work with the US ... current rehabilitation practices. They will also make,recommendations for ... to,injured soldiers and other military personnel in need ...
... findings suggest men fighting over women took place even in ... fighting over women? Nothing new there, based on the findings ... Durham University-led researchers say that genetic evidence from 34 skeletons ... the result of a tribal war over the need for ...
... The Blinded,American Veterans Foundation (BAVF), at its June ... Delegate Sheila Hixson., "We,re honored to recognize Delegate ... District 20 and to the entire State of,Maryland," said ... efforts as a legislator and community activist are known,throughout ...
... Leading Cause of Work Disability in Europe, ... that treating patients with early, active rheumatoid arthritis ... in an,indirect cost savings of euro 4,845 (or ... the study) per patient per year compared to,MTX ...
... Effort to Find Cure, WASHINGTON, June 12 ... died in 2005 of peritoneal,mesothelioma, will be a ... June 27th, part of the Mesothelioma Applied Research ... 26th through Saturday, June 28th at the Hyatt ...
Cached Medicine News:Health News:1 in 10 adults has a non-earlobe piercing 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5Health News:Pursuit of Females Dates Way, Way Back 2Health News:Blinded Vets Foundation to Honor Maryland State Delegate Sheila Hixson 2Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 2Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 3Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 4Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 5Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 6Health News:HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity 7Health News:Asbestos Tragedy and Hope 2
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The uncemented hip joint prosthesis system....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: